TC
Timothy Coughlin (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $501K of TVTX (10,000 sh × $50.07, as filed), executed Jun 12. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$642K
shares × price, as filed
Last traded
Jun 12
Filed Jun 16
Median ADV $123.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
TVTXRecent filings
TVTXSALE
Travere Therapeutics, Inc.
View filing →
$501K10,000 sh × $50.07
Exec Jun 12
Filed Jun 16 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $141K
3,250 sh × $43.49
Exec May 15
Filed May 19 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $631K
18,000 sh × $35.03
Exec Oct 31 2025
Filed Nov 4 2025 · 5:30 PM ET